Biotechnology News

Giraffe Bio raises $6.4M to scale drop-in biochemical flotation reagents that help mines recover more copper without requiring new equipment.

PROTEXT MOBILITY CHAIRMAN CONFIRMS 831.3 MILLION COMMON SHARES IN SEC FILING - CHAIRMAN AND CEO REAFFIRM ZERO PREFERRED CONVERSIONS

Applied Biologics treats first patient in Phase 3 BIOxHEAL™ clinical trial for diabetic foot ulcers.

Mr. Vat-Ho's appointment adds more than 20 years of oncology, biopharma and capital markets experience, including senior roles in transactions totaling more than $25 billion in aggregate value Mr....

23andMe Research Institute names its first Scientific Advisory Board, uniting leaders in genomics, AI, gene editing, and medicine to support its mission.

WARRENDALE, Pa., Oct. 13, 2026 (GLOBE NEWSWIRE) -- ECM Therapeutics, Inc. today announced early clinical results suggesting its extracellular matrix (ECM) hydrogel, ECMT-100, could meaningfully...

NEW YORK and WALTHAM, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies to...

CAMBRIDGE, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

CARMEL, Ind. and BURLINGTON, Mass., Oct. 13, 2026 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery, development and...

SYDNEY, AUSTRALIA, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a late-stage immunotherapy company targeting cancer and autoimmune...